KAPPA BIOSCIENCE AS

Operating

Utvikling, produksjon og salg av produkter innen næringsmiddel, kosttilskudd og medisin og videre, samt investeringer av enhver art og deltagelse i andre selskap.

Utvikling, produksjon og salg av produkter innen næringsmiddel, kosttilskudd og medisin mv. samt investeringer.

Keywords

productionsoupsbrothartificial honeycaramelartificial concentratesready-made foodssandwichespizzanutritional supplementsyeastmilk substitutesegg productsegg whites

Organization

CEO: KS
Kai Schröder1975
Chairman of the board: TL
Theodore Lee Harris1965
Years since formation: 20 years; since Dec 11, 2006
Type: Limited company
VAT registered: Yes
Number of employees: 43

Ownership

Number of shares and share classes: 1,520,697; 1 share class
Total number of shareholders: 1; company
Belongs to group of

Financials

Total operating income 2025: 664,331,813; NOK
Annual total result 2025: 162,236,842; NOK
Total equity 2025: 458,410,819; NOK

Last update: Aug 12, 2026

Management

Management / administration

Name	Role	Shares
KS Kai Schröder 1975	Managing Director/CEO	-

Board

Name	Role	Shares
TL Theodore Lee Harris 1965	Chairman	-
JL Job Leonard Anthonie Van Gunsteren 1976	Board Member	-

Others

Name	Role	Shares
C CEDRA NORGE MOMENTUM AS	Auditor	-
A AMESTO ACCOUNTHOUSE AS	Accountant	-

Last update: Jul 2, 2026

Ownership

Company shareholders

Name	Share class	Total number of shares	Share
K KECHU BIDCO AS	Ordinary shares	1,520,697	100 %

Shares owned by the KAPPA BIOSCIENCE AS

Name	Share class	Total number of shares	Share
K KAPPA SOLUTIONS AS Closed	Ordinary shares	900	100 %

Last update: Jun 2, 2025

Group structure

KECHU BIDCO AS
Total operating income 2025: NOK 0
Operating profit 2025: NOK -275,749
Employees: 0

Financials

in NOK

Summary

Year	2025	2024	2023	2022
Total operating income	664,331,813	477,255,236	341,096,128	300,260,348
Annual Total Result	162,236,842	130,839,186	93,101,731	52,101,616
Total assets	964,034,603	711,705,387	574,294,862	470,979,694
Total liabilities	505,623,783	415,531,409	275,580,069	216,896,588
Total equity	458,410,819	296,173,978	298,714,792	254,083,105

P&L

Year	2025	2024	2023	2022
Total operating income	664,331,813	477,255,236	341,096,128	300,260,348
Total operating costs	444,576,512	307,168,565	225,288,459	237,934,701
Operating result	219,755,302	170,086,671	115,807,669	62,325,647
Financial income/costs	-12,151,370	-628,274	-3,101,244	4,977,405
Profit before tax	207,603,932	169,458,397	112,706,425	67,303,052
Total tax & extraordinary income/cost	45,367,090	38,619,211	19,604,694	15,201,436
Annual Total Result	162,236,842	130,839,186	93,101,731	52,101,616

Balance overview

Year	2025	2024	2023	2022
Total fixed assets	428,178,027	429,797,879	362,758,516	256,221,963
Total current assets	535,856,576	281,907,508	211,536,346	214,757,731
Total assets	964,034,603	711,705,387	574,294,862	470,979,694
Short term debt	238,148,509	240,743,557	87,244,515	145,652,231
Long term debt	267,475,275	174,787,853	188,335,554	71,244,357
Total liabilities	505,623,783	415,531,409	275,580,069	216,896,588
Contributed capital	193,512,914	84,312,914	84,312,914	84,312,914
Retained earnings	264,897,906	211,861,064	214,401,879	169,770,191
Total equity	458,410,819	296,173,978	298,714,792	254,083,105
Total equity and liabilities	964,034,603	711,705,387	574,294,862	470,979,693

Classification

21st company classification

BETA

Industrial large enterprise

KAPPA BIOSCIENCE AS990 476 357